Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023

Upgrades

Alliance Global Partners upgraded the previous rating for KNOT Offshore Partners LP KNOP from Neutral to Buy. KNOT Offshore Partners earned $0.04 in the first quarter, compared to $0.79 in the year-ago quarter. The stock has a 52-week-high of $18.67 and a 52-week-low of $4.28. At the end of the last trading period, KNOT Offshore Partners closed at $4.80.

Ladenburg Thalmann upgraded the previous rating for Advaxis Inc ADXS from Neutral to Buy. The stock has a 52-week-high of $7.20 and a 52-week-low of $0.65. At the end of the last trading period, Advaxis closed at $0.85.

For ChargePoint Holdings Inc CHPT, B of A Securities upgraded the previous rating of Neutral to Buy. ChargePoint Hldgs earned $0.13 in the fourth quarter, compared to $0.17 in the year-ago quarter. The current stock performance of ChargePoint Hldgs shows a 52-week-high of $19.92 and a 52-week-low of $7.82. Moreover, at the end of the last trading period, the closing price was at $8.49.

For Elevation Oncology Inc ELEV, SVB Securities upgraded the previous rating of Market Perform to Outperform. For the first quarter, Elevation Oncology had an EPS of $0.50, compared to year-ago quarter EPS of $0.74. The stock has a 52-week-high of $5.89 and a 52-week-low of $0.72. At the end of the last trading period, Elevation Oncology closed at $5.02.

According to Vertical Research, the prior rating for Heico Corp HEI was changed from Hold to Buy. For the second quarter, Heico had an EPS of $0.76, compared to year-ago quarter EPS of $0.62. The current stock performance of Heico shows a 52-week-high of $180.59 and a 52-week-low of $127.17. Moreover, at the end of the last trading period, the closing price was at $159.30.

According to Jefferies, the prior rating for Ford Motor Co F was changed from Hold to Buy. Ford Motor earned $0.63 in the first quarter, compared to $0.38 in the year-ago quarter. The stock has a 52-week-high of $16.68 and a 52-week-low of $10.62. At the end of the last trading period, Ford Motor closed at $12.09.

Roth MKM upgraded the previous rating for Boston Beer Co Inc SAM from Neutral to Buy. Boston Beer Co earned $0.73 in the first quarter, compared to $0.16 in the year-ago quarter. The stock has a 52-week-high of $420.50 and a 52-week-low of $287.01. At the end of the last trading period, Boston Beer Co closed at $317.85.

For Constellation Brands Inc STZ, Roth MKM upgraded the previous rating of Neutral to Buy. For the fourth quarter, Constellation Brands had an EPS of $1.98, compared to year-ago quarter EPS of $2.37. At the moment, the stock has a 52-week-high of $261.23 and a 52-week-low of $208.12. Constellation Brands closed at $232.88 at the end of the last trading period.

For Equitrans Midstream Corp ETRN, RBC Capital upgraded the previous rating of Sector Perform to Outperform. For the first quarter, Equitrans Midstream had an EPS of $0.22, compared to year-ago quarter EPS of $0.14. The current stock performance of Equitrans Midstream shows a 52-week-high of $9.89 and a 52-week-low of $4.60. Moreover, at the end of the last trading period, the closing price was at $6.09.

For Coinbase Global Inc COIN, Atlantic Equities upgraded the previous rating of Neutral to Overweight. For the first quarter, Coinbase Glb had an EPS of $0.34, compared to year-ago quarter EPS of $1.98. At the moment, the stock has a 52-week-high of $116.30 and a 52-week-low of $31.55. Coinbase Glb closed at $56.92 at the end of the last trading period.

According to BMO Capital, the prior rating for Alliant Energy Corp LNT was changed from Market Perform to Outperform. In the first quarter, Alliant Energy showed an EPS of $0.65, compared to $0.77 from the year-ago quarter. The current stock performance of Alliant Energy shows a 52-week-high of $64.59 and a 52-week-low of $47.23. Moreover, at the end of the last trading period, the closing price was at $50.97.

See all analyst ratings upgrades.

Downgrades

According to Macquarie, the prior rating for NeoGames SA NGMS was changed from Outperform to Neutral. In the first quarter, NeoGames showed an EPS of $0.20, compared to $0.03 from the year-ago quarter. The current stock performance of NeoGames shows a 52-week-high of $27.77 and a 52-week-low of $10.85. Moreover, at the end of the last trading period, the closing price was at $27.27.

See all analyst ratings downgrades.

Initiations

With a Buy rating, Jefferies initiated coverage on Acelyrin Inc SLRN. The price target seems to have been set at $31.00 for Acelyrin. The stock has a 52-week-high of $25.84 and a 52-week-low of $19.06. At the end of the last trading period, Acelyrin closed at $19.27.

With an Outperform rating, Northland Capital Markets initiated coverage on Tigo Energy Inc TYGO. The price target seems to have been set at $20.00 for Tigo Energy. The stock has a 52-week-high of $21.33 and a 52-week-low of $10.40. At the end of the last trading period, Tigo Energy closed at $10.76.

Craig-Hallum initiated coverage on Heritage Global Inc HGBL with a Buy rating. The price target for Heritage Glb is set to $6.00. Heritage Glb earned $0.08 in the first quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $3.81 and a 52-week-low of $1.15. At the end of the last trading period, Heritage Glb closed at $3.81.

UBS initiated coverage on Kenvue Inc KVUE with a Neutral rating. The price target for Kenvue is set to $28.00. At the moment, the stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. Kenvue closed at $26.30 at the end of the last trading period.

RBC Capital initiated coverage on Viridian Therapeutics Inc VRDN with an Outperform rating. The price target for Viridian Therapeutics is set to $44.00. Viridian Therapeutics earned $1.61 in the first quarter, compared to $0.98 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.00 and a 52-week-low of $9.84. Viridian Therapeutics closed at $23.73 at the end of the last trading period.

With a Buy rating, B of A Securities initiated coverage on Kenvue Inc KVUE. The price target seems to have been set at $30.00 for Kenvue. The current stock performance of Kenvue shows a 52-week-high of $27.80 and a 52-week-low of $25.25. Moreover, at the end of the last trading period, the closing price was at $26.30.

With a Equal-Weight rating, Morgan Stanley initiated coverage on Steris PLC STE. The price target seems to have been set at $206.00 for Steris. In the fourth quarter, Steris showed an EPS of $2.30, compared to $2.04 from the year-ago quarter. The current stock performance of Steris shows a 52-week-high of $235.95 and a 52-week-low of $159.88. Moreover, at the end of the last trading period, the closing price was at $200.44.

Morgan Stanley initiated coverage on The Cooper Companies Inc COO with a Equal-Weight rating. The price target for Cooper Companies is set to $410.00. Cooper Companies earned $2.90 in the first quarter, compared to $3.24 in the year-ago quarter. The current stock performance of Cooper Companies shows a 52-week-high of $395.20 and a 52-week-low of $244.53. Moreover, at the end of the last trading period, the closing price was at $369.39.

RBC Capital initiated coverage on Kenvue Inc KVUE with an Outperform rating. The price target for Kenvue is set to $29.00. The stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. At the end of the last trading period, Kenvue closed at $26.30.

With a Buy rating, Needham initiated coverage on Confluent Inc CFLT. The price target seems to have been set at $35.00 for Confluent. Confluent earned $0.09 in the first quarter, compared to $0.19 in the year-ago quarter. The current stock performance of Confluent shows a 52-week-high of $34.39 and a 52-week-low of $16.60. Moreover, at the end of the last trading period, the closing price was at $28.71.

William Blair initiated coverage on Vertex Pharmaceuticals Inc VRTX with an Outperform rating. In the first quarter, Vertex Pharmaceuticals showed an EPS of $3.05, compared to $3.52 from the year-ago quarter. The stock has a 52-week-high of $354.46 and a 52-week-low of $243.25. At the end of the last trading period, Vertex Pharmaceuticals closed at $329.99.

TD Cowen initiated coverage on Acelyrin Inc SLRN with an Outperform rating. At the moment, the stock has a 52-week-high of $25.84 and a 52-week-low of $19.06. Acelyrin closed at $19.27 at the end of the last trading period.

With a Neutral rating, Exane BNP Paribas initiated coverage on Kenvue Inc KVUE. The price target seems to have been set at $28.00 for Kenvue. At the moment, the stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. Kenvue closed at $26.30 at the end of the last trading period.

Citigroup initiated coverage on Kenvue Inc KVUE with a Neutral rating. The price target for Kenvue is set to $28.00. At the moment, the stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. Kenvue closed at $26.30 at the end of the last trading period.

With an Overweight rating, Piper Sandler initiated coverage on Acelyrin Inc SLRN. The price target seems to have been set at $68.00 for Acelyrin. The stock has a 52-week-high of $25.84 and a 52-week-low of $19.06. At the end of the last trading period, Acelyrin closed at $19.27.

With a Equal-Weight rating, Barclays initiated coverage on Paylocity Holding Corp PCTY. The price target seems to have been set at $199.00 for Paylocity Holding. For the third quarter, Paylocity Holding had an EPS of $1.74, compared to year-ago quarter EPS of $1.22. The stock has a 52-week-high of $275.48 and a 52-week-low of $152.12. At the end of the last trading period, Paylocity Holding closed at $172.61.

With a Hold rating, Deutsche Bank initiated coverage on Kenvue Inc KVUE. The price target seems to have been set at $27.00 for Kenvue. At the moment, the stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. Kenvue closed at $26.30 at the end of the last trading period.

Goldman Sachs initiated coverage on Kenvue Inc KVUE with a Neutral rating. The price target for Kenvue is set to $29.00. At the moment, the stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. Kenvue closed at $26.30 at the end of the last trading period.

With an Overweight rating, JP Morgan initiated coverage on Kenvue Inc KVUE. The price target seems to have been set at $29.00 for Kenvue. The stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. At the end of the last trading period, Kenvue closed at $26.30.

See all analyst ratings initiations.